Inventor · disambiguated record
Blair T. Lapointe
Also filed as: LAPOINTE BLAIR T
18 granted patents·1 pending application·118 citations·filing 2013–2022
93Inventor score
Top patents by PatentIndex Score
19 records- 0194US9663522B23-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted May 30, 2017·15 cites·22 claims
- 0292US10221146B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Mar 5, 2019·6 cites·18 claims
- 0392US9809561B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·8 cites·16 claims
- 0492US9663502B22-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted May 30, 2017·12 cites·26 claims
- 0592US9657033B2Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2013·Granted May 23, 2017·20 cites·44 claims
- 0690US9556168B2N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·16 cites·23 claims
- 0789US9487490B23-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Nov 8, 2016·15 cites·24 claims
- 0887US10377768B2Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Aug 13, 2019·6 cites·28 claims
- 0986US9745265B24-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Aug 29, 2017·9 cites·29 claims
- 1085US10287272B2Substituted indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted May 14, 2019·3 cites·30 claims
- 1178US11161854B2Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Nov 2, 2021·2 cites·10 claims
- 1278US10221142B2Substituted pyrazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·3 cites·29 claims
- 1378US10196354B24-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2017·Granted Feb 5, 2019·2 cites·29 claims
- 1471US10344000B2Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted Jul 9, 2019·1 cites·23 claims
- 1567US10689369B2Substituted indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2019·Granted Jun 23, 2020·0 cites·24 claims
- 1665US10745364B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2019·Granted Aug 18, 2020·0 cites·18 claims
- 1755US2024308980A1Heteroaryl amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1846US11174248B2Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Nov 16, 2021·0 cites·11 claims
- 1945US10584121B2Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted Mar 10, 2020·0 cites·23 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →